Biomarkers May Help Develop Better and More Personalized Alzheimer’s Treatments, Study Suggests

Biomarkers May Help Develop Better and More Personalized Alzheimer’s Treatments, Study Suggests
The physical properties of proteins in the spinal fluid and blood of people with Alzheimer’s disease may constitute valuable biomarkers to help diagnose disease progression and predict patients’ outcomes, new research from The Ohio State University suggests. The biomarkers may help researchers develop better treatments in the future, especially for later stages of the disease. The study “Computational

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. frederick numkena says:

    I have read about the IL-33 studies, Protein injections from 2014, where has this gone, what became of it?

Leave a Comment

Your email address will not be published. Required fields are marked *